Back to User profile » Prof. Dr. Masakazu Ichinose

Papers published by Prof. Dr. Masakazu Ichinose:


Long-Term Safety and Efficacy of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Reisner C, Dorinsky P

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2993-3002

Published Date: 23 December 2019

Efficacy and Safety of Budesonide/Glycopyrrolate/Formoterol Fumarate Metered Dose Inhaler Formulated Using Co-Suspension Delivery Technology in Japanese Patients with COPD: A Subgroup Analysis of the KRONOS Study

Ichinose M, Fukushima Y, Inoue Y, Hataji O, Ferguson GT, Rabe KF, Hayashi N, Okada H, Takikawa M, Bourne E, Ballal S, DeAngelis K, Aurivillius M, Dorinsky P, Reisner C

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2979-2991

Published Date: 23 December 2019

Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study [Erratum]

Minakata Y, Motegi T, Ueki J, Gon Y, Nakamura S, Anzai T, Hirata K, Ichinose M

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:2061-2064

Published Date: 3 September 2019

Effect of tiotropium/olodaterol on sedentary and active time in patients with COPD: post hoc analysis of the VESUTO® study

Minakata Y, Motegi T, Ueki J, Gon Y, Nakamura S, Anzai T, Hirata K, Ichinose M

International Journal of Chronic Obstructive Pulmonary Disease 2019, 14:1789-1801

Published Date: 7 August 2019

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study [Corrigendum]

Ichinose M, Nishimura M, Akimoto M, Kurotori Y, Zhao Y, de la Hoz A, Mishima M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:3587-3588

Published Date: 30 October 2018

COPD uncovered: a cross-sectional study to assess the socioeconomic burden of COPD in Japan

Igarashi A, Fukuchi Y, Hirata K, Ichinose M, Nagai A, Nishimura M, Yoshisue H, Ohara K, Gruenberger JB

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2629-2641

Published Date: 28 August 2018

Tiotropium/olodaterol versus tiotropium in Japanese patients with COPD: results from the DYNAGITO study

Ichinose M, Nishimura M, Akimoto M, Kurotori Y, Zhao Y, de la Hoz A, Mishima M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:2147-2156

Published Date: 13 July 2018

Efficacy of tiotropium/olodaterol on lung volume, exercise capacity, and physical activity

Ichinose M, Minakata Y, Motegi T, Ueki J, Gon Y, Seki T, Anzai T, Nakamura S, Hirata K

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1407-1419

Published Date: 1 May 2018

Physical inactivity is associated with decreased growth differentiation factor 11 in chronic obstructive pulmonary disease

Tanaka R, Sugiura H, Yamada M, Ichikawa T, Koarai A, Fujino N, Yanagisawa S, Onodera K, Numakura T, Sato K, Kyogoku Y, Sano H, Yamanaka S, Okazaki T, Tamada T, Miura M, Takahashi T, Ichinose M

International Journal of Chronic Obstructive Pulmonary Disease 2018, 13:1333-1342

Published Date: 24 April 2018

Lung function and long-term safety of tiotropium/olodaterol in East Asian patients with chronic obstructive pulmonary disease

Bai C, Ichinose M, Lee SH, Lee KH, Jöns O, Bothner U, Zhao Y, Buhl R

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:3329-3339

Published Date: 20 November 2017

Prevalence and characteristics of asthma–COPD overlap syndrome identified by a stepwise approach

Inoue H, Nagase T, Morita S, Yoshida A, Jinnai T, Ichinose M

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:1803-1810

Published Date: 20 June 2017

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey [Corrigendum]

Müllerová H, Landis SH, Aisanov Z, Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM, van der Molen T, Oh YM, Tabberer M, Han MK

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:859-860

Published Date: 15 March 2017

Indacaterol/glycopyrronium versus salmeterol/fluticasone in Asian patients with COPD at a high risk of exacerbations: results from the FLAME study

Wedzicha JA, Zhong N, Ichinose M, Humphries M, Fogel R, Thach C, Patalano F, Banerji D

International Journal of Chronic Obstructive Pulmonary Disease 2017, 12:339-349

Published Date: 19 January 2017

Health behaviors and their correlates among participants in the Continuing to Confront COPD International Patient Survey

Müllerová H, Landis SH, Aisanov Z, Davis KJ, Ichinose M, Mannino DM, Maskell J, Menezes AM, van der Molen T, Oh YM, Tabberer M, Han MK

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:881-890

Published Date: 27 April 2016

Prevention of COPD exacerbation by lysozyme: a double-blind, randomized, placebo-controlled study

Fukuchi Y, Tatsumi K, Inoue H, Sakata Y, Shibata K, Miyagishi H, Marukawa Y, Ichinose M

International Journal of Chronic Obstructive Pulmonary Disease 2016, 11:831-838

Published Date: 21 April 2016

Biomarker-based detection of asthma–COPD overlap syndrome in COPD populations

Tamada T, Sugiura H, Takahashi T, Matsunaga K, Kimura K, Katsumata U, Takekoshi D, Kikuchi T, Ohta K, Ichinose M

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:2169-2176

Published Date: 9 October 2015

Efficacy and safety of the long-acting β2-agonist olodaterol over 4 weeks in Japanese patients with chronic obstructive pulmonary disease

Ichinose M, Takizawa A, Izumoto T, Tadayasu Y, Hamilton AL, Kunz C, Fukuchi Y

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1673-1683

Published Date: 20 August 2015

Effects of pharmacologic treatment based on airflow limitation and breathlessness on daily physical activity in patients with chronic obstructive pulmonary disease

Minakata Y, Morishita Y, Ichikawa T, Akamatsu K, Hirano T, Nakanishi M, Matsunaga K, Ichinose M

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:1275-1282

Published Date: 3 July 2015

Continuing to Confront COPD International Surveys: comparison of patient and physician perceptions about COPD risk and management

Menezes AM, Landis SH, Han MK, Muellerova H, Aisanov Z, van der Molen T, Oh YM, Ichinose M, Mannino DM, Davis KJ

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:159-172

Published Date: 20 January 2015

Continuing to Confront COPD International Physician Survey: physician knowledge and application of COPD management guidelines in 12 countries

Davis KJ, Landis SH, Oh YM, Mannino DM, Han MK, van der Molen T, Aisanov Z, Menezes AM, Ichinose M, Muellerova H

International Journal of Chronic Obstructive Pulmonary Disease 2015, 10:39-55

Published Date: 30 December 2014

Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013

Landis SH, Muellerova H, Mannino DM, Menezes AM, Han MK, van der Molen T, Ichinose M, Aisanov Z, Oh YM, Davis KJ

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:597-611

Published Date: 6 June 2014